Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion

Gynuity Health Projects

Status

Completed

Conditions

Termination of Pregnancy

Treatments

Drug: Mifepristone

Study type

Interventional

Funder types

Other

Identifiers

NCT01811056

1006

Details and patient eligibility

About

This study will test ways to give women more options and flexibility when they are ending their unwanted pregnancies. The investigators will look at uptake and acceptability of using mifepristone outside of the clinic for pregnancy termination.

Full description

This study will investigate the uptake of mifepristone administration outside of the health center for pregnancy termination and its acceptability to women and to their providers. In addition, we plan to evaluate rates of follow-up, adherence, efficacy, complications, days of missed work and/or school, and lost income. This will be a prospective, comparative, non-randomized, open-label study. All women who are seeking medical abortion will be offered participation in the study. Women who enroll in the study will be given a choice between taking the mifepristone outside the center or in the center setting.

Enrollment

401 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Women 18 years and older
seeking medical abortion services
in general good health
assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken
eligible for medical abortion according to clinician and center standards.

Exclusion criteria